Clinical Trial Update: Feeding Tolerance and Growth of Preterm Infants Consuming a Supplement Containing Two Human Milk Oligosaccharides (HMOs) [NA]

View source ↗

Summary

This clinical trial is assessing feeding tolerance and growth in preterm, low birthweight infants given a supplement with two human milk oligosaccharides (HMOs)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Birth Weight
• Preterm Birth

Drugs mentioned

• HMOs supplement (two human milk oligosaccharides) (two human milk oligosaccharides (HMOs))

Snippet

Sponsor: Société des Produits Nestlé (SPN) | Conditions: Premature Infant, Low Birthweight Infant | NA | Status: RECRUITING